ANN GONZALEZ: Open Payments
NPI 1083116230 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 26 payments from 11 companies in 2025. Trend: 2023 $1,372 · 2024 $1,430 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $273 |
| AstraZeneca Pharmaceuticals LP | 3 | $138 |
| Dexcom, Inc. | 4 | $74 |
| Novo Nordisk Inc | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: OTEZLA, REPATHA, BREZTRI, Dexcom G6 Transmitter, REXULTI, SPRAVATO, AIRSUPRA, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
